SALT LAKE CITY--(BUSINESS WIRE)--Ken Reali, president and CEO of Clinical Innovations, will share his vision for ethical business conduct as a keynote speaker at the Asia-Pacific Economic Cooperation (APEC) forum on Tuesday, September 10, in Santiago, Chile.
Reali, who is also board chairman of the Advanced Medical Technology Association (AdvaMed) Ethics & Health Care Compliance Committee, will discuss how ethics impact return on investment and what “tone at the top” means for small and medium enterprises in 21st century healthcare systems. His address will come during the second day of APEC’s Business Ethics for Small- and Medium-Sized Enterprises (SMEs) Forum, an annual gathering of public, private and civic enterprise organizations from across the globe.
The APEC Business Ethics for SMEs Forum is expected to draw more than 200 international organizations, including 15 AdvaMed member companies. The forum is focused on how government strategies and private enterprise can advance business ethics across the Asia-Pacific region.
“Leading with integrity isn’t just the right thing to do – it drives results and return on investment,” Reali said. “As we navigate increasingly complex global challenges, how we serve patients, how our principles guide us and how we deliver value are inherently and inextricably linked.”
Clinical Innovations is one of the world’s largest medical device companies focused on labor and delivery and neonatal intensive care. With its market-leading devices used in more than 90 countries, the company has quickly grown its global footprint in recent years, expanding to new territories while also building a direct commercial organization in more developed markets such as the United States, Western Europe, Australia and China.
Clinical Innovations products, including the ROM Plus® Rupture of Membranes Test, ClearView® Uterine Manipulator, Kiwi® Vacuum-Assisted Delivery System, babyLance™ Safety Heel Stick and Koala® Intrauterine Pressure Catheter, are used to improve health outcomes for millions of mothers and babies each year.
Clinical Innovations is owned by leading investment firm EQT.
About Clinical Innovations
Clinical Innovations is one of the largest medical device companies exclusively focused on labor and delivery and neonatal intensive care. The company is a market-leader in several categories with products such as the Koala® Intrauterine Pressure Catheter, Kiwi® Vacuum-Assisted Delivery System, ROM Plus® Rupture of Membranes Test, traxi® Panniculus Retractor, ClearView® Uterine Manipulator and the babyLance™ Safety heel stick. Clinical Innovations is expanding its global presence while directly researching and developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and their babies throughout the world. Clinical Innovations is an EQT portfolio company. For more information, visit clinicalinnovations.com.
EQT is a leading investment firm with approximately EUR 61 billion in raised capital across 29 funds. EQT funds have portfolio companies in Europe, Asia and the U.S. with total sales of more than EUR 19 billion and approximately 110,000 employees. EQT is an active investor and owner in the health care sector, including investments in Certara, Press Ganey, Ottobock, Sivantos, and Lima. EQT works with portfolio companies to achieve sustainable growth, operational excellence and market leadership. For more information, visit EQTpartners.com.
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.